BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17699766)

  • 1. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.
    Filippov V; Filippova M; Duerksen-Hughes PJ
    Cancer Res; 2007 Aug; 67(16):7621-30. PubMed ID: 17699766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes.
    Filippov V; Schmidt EL; Filippova M; Duerksen-Hughes PJ
    Gene; 2008 Aug; 420(1):34-41. PubMed ID: 18571879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Pnn expression attenuates expression levels of SR family splicing factors and modulates alternative pre-mRNA splicing in vivo.
    Chiu Y; Ouyang P
    Biochem Biophys Res Commun; 2006 Mar; 341(2):663-71. PubMed ID: 16430868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway.
    Morgado-Palacin L; Llanos S; Urbano-Cuadrado M; Blanco-Aparicio C; Megias D; Pastor J; Serrano M
    Carcinogenesis; 2014 Dec; 35(12):2822-30. PubMed ID: 25344835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
    Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
    Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
    Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
    Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling of DNA damage is not sufficient to induce p53 response: (re)activation of wt p53 protein strongly depends on cellular context.
    Wesierska-Gadek J; Gueorguieva M; Komina O; Schmid G; Kramer MP
    J Cell Biochem; 2008 Apr; 103(5):1607-20. PubMed ID: 17879942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
    Butz K; Geisen C; Ullmann A; Spitkovsky D; Hoppe-Seyler F
    Int J Cancer; 1996 Nov; 68(4):506-13. PubMed ID: 8945623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
    Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
    Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
    Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Notch1 gene expression by p53 in epithelial cells.
    Yugawa T; Handa K; Narisawa-Saito M; Ohno S; Fujita M; Kiyono T
    Mol Cell Biol; 2007 May; 27(10):3732-42. PubMed ID: 17353266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6.
    Incassati A; Patel D; McCance DJ
    Oncogene; 2006 Apr; 25(17):2444-51. PubMed ID: 16369493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.